JPH0352473B2 - - Google Patents

Info

Publication number
JPH0352473B2
JPH0352473B2 JP58021396A JP2139683A JPH0352473B2 JP H0352473 B2 JPH0352473 B2 JP H0352473B2 JP 58021396 A JP58021396 A JP 58021396A JP 2139683 A JP2139683 A JP 2139683A JP H0352473 B2 JPH0352473 B2 JP H0352473B2
Authority
JP
Japan
Prior art keywords
formula
compound
pharmacologically acceptable
acid addition
addition salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58021396A
Other languages
English (en)
Japanese (ja)
Other versions
JPS58148888A (ja
Inventor
Kaa Aa Gigaa Rudorufu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of JPS58148888A publication Critical patent/JPS58148888A/ja
Publication of JPH0352473B2 publication Critical patent/JPH0352473B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP58021396A 1982-02-12 1983-02-10 麦角アルカロイド類 Granted JPS58148888A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH893/82 1982-02-12
CH89382 1982-02-12
CH6924/82 1982-11-29

Publications (2)

Publication Number Publication Date
JPS58148888A JPS58148888A (ja) 1983-09-05
JPH0352473B2 true JPH0352473B2 (cs) 1991-08-12

Family

ID=4197630

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58021396A Granted JPS58148888A (ja) 1982-02-12 1983-02-10 麦角アルカロイド類

Country Status (6)

Country Link
JP (1) JPS58148888A (cs)
BE (1) BE895842A (cs)
FR (1) FR2528850B1 (cs)
HU (1) HU187003B (cs)
SU (1) SU1189351A3 (cs)
ZA (1) ZA83955B (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3649599A (en) * 1998-04-16 1999-11-01 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Salivary prolactin test for serotonergic activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH505102A (de) * 1967-11-01 1971-03-31 Sandoz Ag Verfahren zur Herstellung neuer Mutterkornpeptidalkaloide
US3891652A (en) * 1973-06-28 1975-06-24 Squibb & Sons Inc Antianginal aryldecahydropyrrolo{8 3,4-f{9 quinolines
CH602765A5 (cs) * 1974-09-27 1978-07-31 Sandoz Ag

Also Published As

Publication number Publication date
JPS58148888A (ja) 1983-09-05
BE895842A (fr) 1983-08-08
ZA83955B (en) 1984-09-26
FR2528850A1 (fr) 1983-12-23
SU1189351A3 (ru) 1985-10-30
FR2528850B1 (fr) 1985-07-26
HU187003B (en) 1985-10-28

Similar Documents

Publication Publication Date Title
KR0169134B1 (ko) N-아실-2,3-벤조디아제핀 유도체 및 이 유도체를 함유하는 제약조성물과 이들의 제조방법
US8937179B2 (en) Substituted diketopiperazines and their use as oxytocin antagonists
AU2021367714A1 (en) Crystalline form iv of melanocortin receptor agonist compound and preparation method therefor
JPH01190680A (ja) インドール誘導体およびその製造方法
EP3596079B1 (en) Pharmacologically active aryl-substituted pyrazolo[1,5-a]pyrimidine derivatives
CA2503995A1 (fr) Nouveaux composes de pyridopyrimidinone, leur procede de preparation et les compositions qui les contiennent
JPH0578292A (ja) 三環系化合物
WO1997005129A1 (fr) (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridine-carboxamide, son procede d'obtention et medicament le contenant
JP3922024B2 (ja) １，５−ベンゾジアゼピン誘導体カルシウム塩及びその製造法並びに該化合物を有効成分とする医薬
KR20220151569A (ko) 멜라노코르틴 수용체 작용제 화합물의 결정형 v 및 이의 제조방법
EP0328700A1 (en) 4,7-Dihydropyrazolo(1,5-a)pyrimidine compound and pharmaceutical use thereof
US4737499A (en) Ergotalkaloids for treating senile dementia
JPH0352473B2 (cs)
HK24194A (en) Pyrrolo[1,2-a][4,1]benzoxazepines, process for their preparation, pharmaceutical compositions containing these compounds and therapeutical use
WO2005080333A1 (en) Process for purification of ropinirole
FR2508457A1 (fr) Pyrrolo(2,1-b)quinazolines et pyrido(2,1-b)quinazolines substituees, leur preparation et leurs utilisations therapeutiques
JPH0211592A (ja) 光学活性なジヒドロピリジンホスホン酸エステル
JP3222051B2 (ja) ６−メトキシ−１ｈ−ベンゾトリアゾール−５−カルボキサミド誘導体
JPH11217361A (ja) ナフトキノン化合物及び該化合物からなる医薬
WO1999020623A1 (en) Indole derivative useful as endothelin receptor antagonist
JPH09301972A (ja) Ｎ−（１−置換−アザシクロアルカン−３−イル）カルボキサミド誘導体及びそれを含有する医薬組成物
FI88039B (fi) Foerfarande foer framstaellning av 2,3-dihydro-1-(8-metyl-1,2,4-triatsolo/4,3-b/pyridazin-6-yl)-4(1h)-pyridinon
JPH05105631A (ja) 抗痴呆薬
JP2000256327A (ja) 新規イソキノリン誘導体
WO1995029910A1 (en) Imidazolidinedione derivative